Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
You need to sign in or sign up before continuing.
Close
https://www.empr.com/home/news/drugs-in-the-pipeline/intranasal-nalmefene-gets-priority-review-for-opioid-overdose-treatment/
0
0
Intranasal Nalmefene Gets Priority Review for Opioid Overdose Treatment - Psychiatry Advisor
+ 5 more
2/1/23 at 12:35am
Organization
Empr.com
Authors
Brian Park
PharmD
23 words
0
Comments
OPNT003 is an intranasal formulation containing the high affinity opioid antagonist, nalmefene.
Mental Health
Health
Drugs & Medications
opioid antagonist
OPNT003
Intranasal Nalmefene Gets Priority Review for Opioid Overdose Treatment
nalmefene
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...